July 29, 2021 – BD (Becton, Dickinson and Company) (Franklin Lakes, NJ) announced the company will begin remediation for the February 4, 2020 BD Alaris System recall through a new version of software.
Under U.S. Food and Drug Administration (FDA) guidance, BD will release Alaris System software version 12.1.2 and associated ancillary software to remediate the affected software.
Effective today, customers can begin scheduling remediation by contacting the BD Recall Support Center at 1-888-562-6018.
The new software, which will be available at no cost to customers, is expected to remediate the issues identified in the February 4, 2020 recall notice and provide programming, operational and cybersecurity updates to affected devices; however, this software update has not been reviewed or cleared by the FDA.
The BD Alaris System allows clinicians to deliver medications, fluids and blood products through a single integrated platform that includes large volume pumps, syringe pumps and patient-controlled analgesia (PCA) modules for adult, pediatric and neonatal patients.